PHASTAR’s Japan office opened in June 2020 in Tokyo and marks our 12th global office and our first in Asia. Our Tokyo office is led by our recently appointed Director of Biostatistics Ryan Hara, who brings to PHASTAR extensive experience in the pharmaceutical and CRO industry and leading clinical analytics departments in China and Japan.
PHASTAR’s Tokyo office offers our award-winning technical expertise to a wider range of customers, as well as attracting additional talent with experience in clinical study design and reporting. Furthermore, our customers will now have on the ground access to PHASTAR’s 3,700 years combined technical experience, locally available. Senior staff at our Tokyo office will continue to enhance our customer interactions.
Our number one priority is to ensure that the work we produce is of the highest quality: every project PHASTAR undertakes is supervised on methodology and utilises internal processes designed to ensure optimal quality. See our range of services below: